Trial Details
COMPLETEDBasic Information
| Clinical ID | c1587 |
|---|---|
| Identifier | NCT00577473 |
| Trial Title | Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: mesalamine|DRUG: mesalamine |
Participant Information
| Sponsor | Warner Chilcott |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-02-01 |
|---|---|
| Primary Completion Date | 2025-02-03 |
| Completion Date | 2025-02-03 |